Work

GLP-1 receptor agonists vs 5-alpha reductase inhibitors for prostate cancer primary prevention in high-risk men: A real-world head-to-head comparison.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e17134

Authors: Oscar Hinojosa, Nico-al Paolo Gotera, Jonathan Dao, Ariana N. Neely, Arshi Syal, Yajur Arya, Viral M. Patel, Colton Jones

Institutions: The University of Texas at San Antonio Health Science Center, Mercy Medical Center North Iowa, Jefferson Einstein Philadelphia Hospital, Mayo Clinic in Florida, The University of Texas Southwestern Medical Center, The University of Texas at San Antonio

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162695089

Cites:

Cited by:

Related to: